Form 4 for TXG 10x Genomics, Inc.
Accepted 2021-10-07 00:00:00 ET · period of report 2021-10-05 · accession 0001567619-21-018030 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-10-07 | 2021-10-05 | TXG | Saxonov Serge | CEO, Dir | S - Sale+OE | $143.50 | -15.0K | 902.1K | -2% | -$2.15M |
| DM | 2021-10-07 | 2021-10-05 | TXG | Saxonov Serge | CEO, Dir | M - OptEx | $7.61 | +8,668 | 903.7K | +1.0% | +$66.0K |
| DM | 2021-10-07 | 2021-10-05 | TXG | Saxonov Serge | CEO, Dir | M - OptEx | $0.00 | -8,668 | 63.7K | -12% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2021-10-05 | S | D | 1,900 | $144.40 | 894,156 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $143.96 to $144.95. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 2 | Common | Class A Common Stock | 2021-10-05 | S | D | 1,720 | $145.42 | 892,436 | D | — | — | (F5) This transaction was executed in multiple trades at prices ranging from $144.96 to $145.93. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 3 | Common | Class A Common Stock | 2021-10-05 | S | D | 300 | $146.12 | 892,136 | D | — | — | (F6) This transaction was executed in multiple trades at prices ranging from $146.02 to $146.17. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 4 | Common | Class A Common Stock | 2021-10-05 | S | D | 6,056 | $143.40 | 896,056 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $142.96 to $143.94. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 5 | Common | Class A Common Stock | 2021-10-05 | M | A | 3,460 | $11.48 | 907,136 | D | — | — | |
| 6 | Common | Class A Common Stock | 2021-10-05 | S | D | 5,024 | $142.47 | 902,112 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $141.94 to $142.93. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 7 | Common | Class A Common Stock | 2021-10-05 | M | A | 5,208 | $5.04 | 903,676 | D | — | — | |
| 8 | Derivative | Stock Option (right to buy) | 2021-10-05 | M | D | 3,460 | $0.00 | 54,670 | D | $11.48 · — to 2029-05-10 | 3,460 Class A Common Stock | (F10) This option, originally for 145,786 shares, of which 91,116 have been exercised, vested as to 1/48th of the shares on May 1, 2019, and 1/48th of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. |
| 9 | Derivative | Stock Option (right to buy) | 2021-10-05 | M | D | 5,208 | $0.00 | 63,740 | D | $5.04 · — to 2028-11-02 | 5,208 Class A Common Stock | (F9) This option, originally for 250,000 shares, of which 186,260 have been exercised, vested as to 1/48th of the shares on October 1, 2018, and 1/48th of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. |